# FDA Inspection 1107699 - Sato Pharmaceutical Co., Ltd. - October 25, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/sato-pharmaceutical-co-ltd/eb00e326-37ea-4419-aaed-a041aad13d5a
Source feed: FDA_Inspections

> FDA Inspection 1107699 for Sato Pharmaceutical Co., Ltd. on October 25, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1107699
- Company Name: Sato Pharmaceutical Co., Ltd.
- Inspection Date: 2019-10-25
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1292356 - 2025-11-21](https://www.globalkeysolutions.net/records/fda_inspections/sato-pharmaceutical-co-ltd/78dc6783-6b60-4d11-99c6-bd1e12334c10)
- [FDA Inspection 1111704 - 2019-11-07](https://www.globalkeysolutions.net/records/fda_inspections/sato-pharmaceutical-co-ltd/f303b0c8-052c-479f-a5eb-cee80b3d9998)
- [FDA Inspection 1111704 - 2019-11-07](https://www.globalkeysolutions.net/records/fda_inspections/sato-pharmaceutical-co-ltd/4153faa6-6265-49c5-8afe-9a961309bc2f)
- [FDA Inspection 1064716 - 2018-07-03](https://www.globalkeysolutions.net/records/fda_inspections/sato-pharmaceutical-co-ltd/9a4b8420-d982-428c-88b5-2785907b264c)
- [FDA Inspection 961508 - 2016-02-12](https://www.globalkeysolutions.net/records/fda_inspections/sato-pharmaceutical-co-ltd/7220a26f-ea4c-4152-b9aa-a7142357e82f)

Company: https://www.globalkeysolutions.net/companies/sato-pharmaceutical-co-ltd/5e274c7f-ada5-44d9-8c9b-068c7392b4ea

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
